Cancer News and Research

Latest Cancer News and Research

Where there’s no smoke, there’s less bladder cancer

Giving up smoking can significantly improve clinical outcomes in patients with urothelial carcinoma of the bladder, report US researchers.

29 Aug 2012

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

Sleep disorders are a large area. We are focused on one particular type of sleep disturbance called “non-restorative” sleep. People with this problem do sleep, but they don’t wake up feeling refreshed or feeling that their sleep has had the restorative effects of healthy sleep.

29 Aug 2012

New method simplifies pharmaceutical production of proteins

Engineering researchers at the University of Arkansas have developed a method to simplify the pharmaceutical production of proteins used in drugs that treat a variety of diseases and health conditions, including diabetes, cancer, arthritis and macular degeneration.

29 Aug 2012

Anova Cancer Care to participate in CyberKnife research study

Anova Cancer Care has been chosen to participate in a landmark national prostate cancer study. The goal of the two-year study is to determine the best treatments for prostate cancer. The study will look specifically at prostate cancer radiosurgery.

29 Aug 2012

UMHS, MidMichigan Health announce plans to affiliate as clinical and business partners

MidMichigan Health and the University of Michigan Health System have announced plans to affiliate as clinical and business partners.

29 Aug 2012

Genetic investigation of tribes may explain why East Asians have lower skin cancer rates

Genetic investigation of a Malaysian tribe may tell scientists why East Asians have light skin but lower skin cancer rates than Europeans, according to a team of international researchers. Understanding the differences could lead to a better way to protect people from skin cancer.

29 Aug 2012

New treatment for severe dry eye is now available at U-M’s Kellogg

A new treatment available at the University of Michigan Kellogg Eye Center—prosthetic replacement of the ocular surface ecosystem or PROSE—provides relief to patients who suffer from severe dry eye, often the result of cancer or complex corneal disease.

29 Aug 2012

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Break apart a couple worm-like chromosomes and they may reconnect with mismatched tips and tails - such is the case of the EML4-ALK fusion gene that creates 2-7 percent of lung cancers. Almost exactly a year ago, the FDA approved the drug crizotinib to treat these ALK+ lung cancer patients, who were likely never smokers. Informed doctors use the test called a FISH assay to check for the EML4-ALK fusion gene, and then if the test is positive, ALK+ patients benefit greatly from crizotinib.

29 Aug 2012

Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging

Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that it is developing CLR1502 (GLOW2), a preclinical cancer-targeted optical imaging agent for intraoperative tumor margin illumination and non-invasive tumor imaging.

29 Aug 2012

Study to investigate how breast cancer patients might benefit from exercise

Researchers in Edmonton and Calgary want to recruit 1,500 breast cancer patients over the next decade to find out how exercise and fitness affects cancer survival and recovery.

29 Aug 2012

Trudeau Institute study holds promise for improved prevention and treatment of bacterial infections

New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and treatment of bacterial infections and the life-threatening complications of chronic inflammation that can result from them.

29 Aug 2012

Acorda’s GGF2 can improve erectile function after cavernous nerve damage

Acorda Therapeutics, Inc. announced data from a preclinical study showed that treatment with Glial Growth Factor 2 (GGF2) improved erectile function in an animal model following a cavernous nerve (CN) injury, a common complication of prostate surgery.

29 Aug 2012

Taking aspirin associated with reduced risk of death from prostate cancer

Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, says a new study that includes a researcher at UT Southwestern Medical Center.

29 Aug 2012

Esperance completes EP 100 and paclitaxel Phase 2 combination trial on advanced ovarian cancer

Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their surfaces.

29 Aug 2012

Scientists identify genes that underlie growth of primitive leukemia stem cells

University of Rochester Medical Center scientists believe they are the first to identify genes that underlie the growth of primitive leukemia stem cells, and then to use the new genetic signature to identify currently available drugs that selectively target the rogue cells.

29 Aug 2012

Top-line results from Rexahn’s Archexin Phase II study on metastatic pancreatic cancer

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.

29 Aug 2012

Study looks at exercise habits among cancer patients

Numerous studies have shown the powerful effect that exercise can have on cancer care and recovery. For patients who have gone through breast or colon cancer treatment, regular exercise has been found to reduce recurrence of the disease by up to 50 percent.

29 Aug 2012

VA report shows improvement in gender disparities in 12 out of 14 HEDIS measures

The Department of Veterans Affairs (VA) has released a report that shows improvement in gender disparities in 12 out of 14 Healthcare Effectiveness Data and Information Set (HEDIS) measures in VA since 2008.

29 Aug 2012

One in four women experience vulvar pain at some point in their lifetime

According to a study conducted by the University of Michigan, one in four women experience vulvar pain at some point in their lifetime. Like all medical concerns, vulvar pain causes both physical and mental stress. Additionally, vulvar pain can have an adverse effect on intimacy and relationships.

29 Aug 2012

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

The FDA last month approved for use a small ingestible sensor that, when embedded into a pill, can help "keep track of whether a patient is taking their medicine on time," Reuters reports.

29 Aug 2012

Cancer News and Research

Latest Cancer News and Research

Where there’s no smoke, there’s less bladder cancer

Sleep disorder treatment: an interview with Dr Seth Lederman, President and CEO of Tonix Pharmaceuticals

New method simplifies pharmaceutical production of proteins

Anova Cancer Care to participate in CyberKnife research study

UMHS, MidMichigan Health announce plans to affiliate as clinical and business partners

Genetic investigation of tribes may explain why East Asians have lower skin cancer rates

New treatment for severe dry eye is now available at U-M’s Kellogg

FISH assay identifies only few lung cancer patients who could benefit from crizotinib

Novelos expects to submit CLR1502 IND with FDA for non-invasive tumor imaging

Study to investigate how breast cancer patients might benefit from exercise

Trudeau Institute study holds promise for improved prevention and treatment of bacterial infections

Acorda’s GGF2 can improve erectile function after cavernous nerve damage

Taking aspirin associated with reduced risk of death from prostate cancer

Esperance completes EP 100 and paclitaxel Phase 2 combination trial on advanced ovarian cancer

Scientists identify genes that underlie growth of primitive leukemia stem cells

Top-line results from Rexahn’s Archexin Phase II study on metastatic pancreatic cancer

Study looks at exercise habits among cancer patients

VA report shows improvement in gender disparities in 12 out of 14 HEDIS measures

One in four women experience vulvar pain at some point in their lifetime

Small, ingestible sensor can track patient medication intake, activity levels; Technology to be tested for TB treatment

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in